Support
DONATE
DONATE
Update on Lutathera® announcement by Novartis

Update on Lutathera® announcement by Novartis

by | May 6, 2022

Some of you may have seen the announcement, by Novartis, that there is a temporary, voluntary suspension of radioligand therapy production: May 5th 2022 — Novartis today announced a temporary, voluntary suspension of production at its radioligand therapy production...
Carcinoid Heart Disease : The Heart of The Matter

Carcinoid Heart Disease : The Heart of The Matter

by | May 2, 2022

Carcinoid Heart Disease (CHD or Hedinger syndrome), is a rare condition that affects about one in five (20%) patients who have a Neuroendocrine Cancer AND Carcinoid Syndrome (CS). The precise cause is unknown but is thought to be related to abnormally raised levels of...
Patient and fundraiser embarks on Devon cycle

Patient and fundraiser embarks on Devon cycle

by | Apr 14, 2022

Please join us in wishing all the luck in the world to Pete, who along with his family and friends, will be embarking on a cycle ride from the north to the south of Devon tomorrow.   You may already be aware of this incredible fundraiser, as Pete has featured in many...